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status and body mass index (BMI) were collected. Handgrip 
strength (HGS) was assessed by a hydraulic hand dynamome-
ter with patient in sitting position with elbow flexed 90 degrees 
in free position of the non-dominant hand. Further, the Short 
Nutritional Assessment Questionnaire (SNAQ) and Malnutrition 
Screening Tool (MST) were completed. An INS was indicated 
by either HGS < 15th percentile, or SNAQ and/or MST score 
≥ 1. Active disease was defined by 2 or more of the following: 
serum CRP > 5 mg/ml, faecal calprotectin > 200 μg/g or doubled, 
and/or increased activity index score (Harvey–Bradshaw Index 
[HBI] ≥ 5 or Simple Clinical Colitis Activity Index [SCCAI] ≥ 
3 points). A  multivariable logistic regression analysis was per-
formed to assess the association between host and disease char-
acteristics and risk of INS for IBD, Crohn’s disease (CD), and 
ulcerative colitis (UC) separately.
Results: In total, 143 IBD patients were included (97 CD and 46 
UC). In IBD, INS was present in 47.6% (42.3% CD and 58.7% 
UC), with active disease in 32.9% (30.9% CD and 37% UC). Mean 
age at diagnosis was 47.8 years (SD 15.3) (CD 46.5 and SD 15.6), 
(UC 50.6) (SD 14.6), and mean BMI was 25.5 kg/m2 (SD 4.1, CD 
25.6) (SD 4.2) (UC 25.1) (SD 3.9). Multivariable analysis showed 
active disease (OR 3.0 95% CI 1.4–6.2, p = 0.003), but not in gen-
der, age, localisation, BMI, smoking status, or IBD subtype to be 
associated with INS in IBD. For UC, active disease (OR 12.3 95% CI 
1.8–86.3, p = 0.012) and female gender (OR 26.6 95% CI 4.1–173.4 
p = 0.001) were associated with INS. No associations were found 
for CD.
Conclusions: The high prevalence of indicators for INS and its 
association with disease activity in the total and UC subpopulation, 
point to the importance of nutritional assessment in IBD patients. 
Dietary guidance may improve their nutritional status and thereby 
QoL.
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Background: Antibiotic-dependent/refractory primary idiopathic 
pouchitis (ADRP) is a significant clinical challenge. Ileo-anal pouch 
inflammation can also be caused by chronic peri-pouch sepsis 
(CPPS). Both may partially respond to empirical treatment with 
antibiotics. However, if a persistent pre-sacral collection is present, 
different treatment such as drainage may be more appropriate, and 
immunosuppressants and biologics should be avoided. This study 
aimed to identify the prevalence of CPPS in patients thought to have 
ADRP. The secondary aims were to identify any specific features on 
pouchoscopy suggesting CPPS and to evaluate outcomes of treat-
ment for CPPS.
Methods: Records of patients who had been managed as ADRP 
over a period of 9 years were reviewed retrospectively. Only those 
with endoscopic evidence of inflammation and who had MRI were 
included. Pouchoscopy findings and outcomes of treatment for CPPS 
were evaluated.
Results: In total, 68 patients were treated as ADRP between March 
2006 and June 2015 (43 male [63%]). MRI pelvis showed a 
pre-sacral collection in 26 patients (38%). Median age at pouch 
formation was 33.5 years (range 16–64), and median time between 
pouch formation and first MRI pelvis was 6 years (range 0–32). 
No significant differences were found in gender, age at pouch 
formation, or time between pouch formation and first MRI pel-
vis between patients with and without a pre-sacral collection. 
Pouchoscopy identified ulcerative inflammation in the lower pouch 
in 13% of patients with a pre-sacral collection and in 26% without 
(p = 0.43).
Examination under anaesthesia was performed in 13 patients (50%) 
with a pre-sacral collection. In 5 (19%), a collection was identified 
and drained; symptoms improved in only 1 of these (4%). The col-
lection was not drained in the other patients (because it was too 
small and was not thought to be contributing to inflammation). They 
remained on antibiotics (69%) or had their pouch defunctioned or 
excised (27%).
Conclusions: In patients thought to have ADRP, 38% had a pre-
sacral collection on MRI. There was no specific feature on pou-
choscopy suggestive of CPPS. The possibility of CPPS should be 
considered early in patients with recurrent or refractory pouchitis 
and MRI pelvis performed. This might lead to earlier detection of the 
collection and prompt appropriate treatment. However, prognosis is 
poor if a CPPS is present.
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Background: Extraintestinal manifestations (EIM) are a common 
feature in inflammatory bowel disease (IBD) and may occur before 
or after IBD diagnosis. The aim of this study was to evaluate the 
frequency, type and chronology of EIM in ulcerative colitis (UC) and 
Cohn’s disease, predictive factors of occurrence of EIM and clinical 
course of IBD in patients with EIM.
Methods: IBD patients with a definitive diagnosis of CD or UC fol-
lowed in our institution were included. Patients with suspected EIM 
still waiting a definitive diagnosis were excluded. Demographic data, 
type and chronology of EIM, influence of EIM on change of treat-
ment, and clinical course of IBD, as evaluated by need of surgery, 
corticosteroids, and immunosuppressants, were collected.
Results: In total, 463 patients with IBD were analysed: 246 with UC 
and 217 with CD, with a mean age of 46 years and a mean follow-
up of 8.8 years. Further, 138 EIM were identified in 109 patients 
(24% of the total population), with a mean of 1.3 EIM per patient. 
Moreover, 74 patients (68%) had arthropathy, 24 (22%) had aph-
tous stomatitis, 24 (22%) had cutaneous manifestations (erythema 
nodosum and pyoderma gangrenosum), 11 (10%) had hepatobiliary 
manifestations (such as autoimmune hepatitis and primary scleros-
ing cholangitis), 2 (2%) had ophthalmological manifestations, and 
3 (3%) cardiopulmonary manifestations. In 73% of the cases, the 
EIM was diagnosed after the IBD; in 11% of the cases before and 
in 16%, there was a concomitant diagnosis of IBD and EIM. CD 
diagnosis (p = 0.017), female gender (p < 0.001), and positive anti-
Saccharomyces cerevisiae antibody (ASCA) serology (p  =  0.015) 
were associated with the development of EIM. Patients with EIM 
were more likely to have had received corticosteroids (p < 0.001), 
to be corticoresresistant or corticodependent (p = 0.005), and to be 
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